Search Results - "Hittner, Helen Mintz"

Refine Results
  1. 1

    Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy by Mintz-Hittner, Helen A., MD, Geloneck, Megan M., MD, Chuang, Alice Z., PhD

    Published in Ophthalmology (Rochester, Minn.) (01-09-2016)
    “…Purpose To determine incidence, risk factors, risk period, and characteristics of recurrent retinopathy of prematurity (ROP) treated by intravitreal…”
    Get full text
    Journal Article
  2. 2

    Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II by Mintz-Hittner, Helen A, Kuffel, Jr, Ronald R

    Published in Retina (Philadelphia, Pa.) (01-06-2008)
    “…To report a retrospective, consecutive, noncomparative case series of moderate and severe stage 3 retinopathy of prematurity (ROP) in zone I or posterior zone…”
    Get full text
    Journal Article
  3. 3

    Review of effects of anti-VEGF treatment on refractive error by Mintz-Hittner, Helen A, Geloneck, Megan M

    Published in Eye and Brain (01-01-2016)
    “…To examine the effect of anti-vascular endothelial growth factor (anti-VEGF) agents on refractive error in the setting of retinopathy of prematurity (ROP)…”
    Get full text
    Journal Article Book Review
  4. 4

    Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity by Mintz-Hittner, Helen A, Kennedy, Kathleen A, Chuang, Alice Z

    Published in The New England journal of medicine (17-02-2011)
    “…In this trial, one intravitreal injection of bevacizumab was administered to treat retinopathy of prematurity of stage 3+. Bevacizumab was more effective than…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity by Kennedy, Kathleen A., Mintz-Hittner, Helen A.

    Published in Journal of AAPOS (01-02-2018)
    “…Infants with stage 3+ retinopathy of prematurity (ROP) in zone I or zone II posterior were randomized to initial treatment with bevacizumab or laser in a…”
    Get full text
    Journal Article
  7. 7

    Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial by Geloneck, Megan M, Chuang, Alice Z, Clark, W Lloyd, Hunt, Michael G, Norman, Alan A, Packwood, Eric A, Tawansy, Khaled A, Mintz-Hittner, Helen A

    Published in JAMA ophthalmology (01-11-2014)
    “…Children born prematurely who develop retinopathy of prematurity (ROP) often develop myopia, and those who require laser treatment may develop very high…”
    Get more information
    Journal Article
  8. 8

    Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies by Sohocki, Melanie M., Daiger, Stephen P., Bowne, Sara J., Rodriquez, Joseph A., Northrup, Hope, Heckenlively, John R., Birch, David G., Mintz-Hittner, Helen, Ruiz, Richard S., Lewis, Richard A., Saperstein, David A., Sullivan, Lori S.

    Published in Human mutation (2001)
    “…Inherited retinopathies are a genetically and phenotypically heterogeneous group of diseases affecting approximately one in 2000 individuals worldwide. For the…”
    Get full text
    Journal Article
  9. 9

    Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors by Mintz-Hittner, Helen A

    Published in Early human development (01-12-2012)
    “…Abstract ROP remains a major cause of childhood blindness worldwide. The smallest, sickest infants develop the most severe forms of zone 1 ROP. Such eyes may…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11

    Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial by Mintz-Hittner, Helen A

    Published in European journal of ophthalmology (01-09-2012)
    “…Both intravitreal pegaptanib with laser therapy and intravitreal bevacizumab monotherapy have been found to be more efficacious than laser therapy alone in…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antivascular endothelial growth factor for retinopathy of prematurity by Mintz-Hittner, Helen A, Best, Leah M

    Published in Current opinion in pediatrics (01-04-2009)
    “…This review will discuss a potentially more effective treatment for retinopathy of prematurity (ROP) with fewer acute and long-term complications. Avastin…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mutations in the human forkhead transcription factor FOXE3 associated with anterior segment ocular dysgenesis and cataracts by SEMINA, Elena V, BROWNELL, Isaac, MINTZ-HITTNER, Helen A, MURRAY, Jeffrey C, JAMRICH, Milan

    Published in Human molecular genetics (01-02-2001)
    “…Dysgenesis of the anterior segment of the eye delineates a spectrum of human developmental disorders that show wide phenotypic and genetic heterogeneity. It is…”
    Get full text
    Journal Article
  16. 16

    A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD by Murray, Jeffrey C, Semina, Elena V, Ferrell, Robert E, Mintz-Hittner, Helen A, Bitoun, Pierre, Alward, Wallace Lee M, Reiter, Rebecca S, Funkhauser, Carrie, Daack-Hirsch, Sandra

    Published in Nature genetics (01-06-1998)
    “…We report here the identification of a new human homeobox gene, PITX3, and its involvement in anterior segment mesenchymal dysgenesis (ASMD) and congenital…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Laser in situ keratomileusis for treated anisometropic amblyopia in awake, autofixating pediatric and adolescent patients by Phillips, Christopher B, Prager, Thomas C, McClellan, Glynett, Mintz-Hittner, Helen A

    Published in Journal of cataract and refractive surgery (01-12-2004)
    “…To establish the safety and efficacy of laser in situ keratomileusis (LASIK) in pediatric and adolescent patients with anisometropic amblyopia who completed…”
    Get more information
    Journal Article
  19. 19

    VSX1 (RINX) mutation with craniofacial anomalies, empty sella, corneal endothelial changes, and abnormal retinal and auditory bipolar cells by Mintz-Hittner, Helen A, Semina, Elena V, Frishman, Laura J, Prager, Thomas C, Murray, Jeffrey C

    Published in Ophthalmology (Rochester, Minn.) (01-04-2004)
    “…To present a previously unreported African American family with 1 variation and 1 mutation of the homeobox transcription factor gene, VSX1 (RINX), and to…”
    Get more information
    Journal Article
  20. 20